Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study

BACKGROUND: To assess the feasibility and early toxicity of selective, IMRT-based dose escalation (simultaneous integrated boost) to biopsy proven dominant intra-prostatic lesions visible on MRI. METHODS: Patients with localized prostate cancer and an abnormality within the prostate on endorectal co...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Singh, Anurag K, Guion, Peter, Sears-Crouse, Nancy, Ullman, Karen, Smith, Sharon, Albert, Paul S, Fichtinger, Gabor, Choyke, Peter L, Xu, Sheng, Kruecker, Jochen, Wood, Bradford J, Krieger, Axel, Ning, Holly
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2007
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075521/
https://ncbi.nlm.nih.gov/pubmed/17877821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-2-36
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares